Active Pharmaceutical Ingredients Market: The global market is expected to grow at a CAGR of 7.2% during the forecasted period.

As per the study initiated by Evolve Business Intelligence, the global Active Pharmaceutical Ingredients Market size accounted for USD 210.5 Billion in 2022, growing at a CAGR of 7.2% from 2023 to 2030. The Active Pharmaceutical Ingredients (API) Market refers to the global pharmaceutical industry segment responsible for the production and distribution of active pharmaceutical ingredients. These ingredients are the essential chemical compounds or substances within a pharmaceutical drug that exert the intended therapeutic effect on the body. APIs are the core components of various medications, including prescription drugs, over-the-counter (OTC) medicines, and biologics.

Request Free Sample Report or PDF Copy:

Key Highlights:

  • The global Active Pharmaceutical Ingredients Market t size was valued at USD 5billion in 2022 growing at a CAGR of 7.2% from 2023 to 2030.
  • North America dominated the market in 2022
  • Asia Pacific is expected to fastest-growing at the highest CAGR from 2023 to 2030

Evolve Business Intelligence has published a new market research report on Global Active Pharmaceutical Ingredients Market focusing in various aspects including market size and forecast, market dynamics, competitors market share analysis, market size in terms of value and volume, SWOT analysis, product benchmarking, key players recent developments, and opportunities, among others. The market has also been analyzed based on 4 indicators in the market dynamic chapter which includes Drivers, Restraints, Key Trends, and Challenges. The overall sum of these sections will help to understand the best strategies to be adopted in order to prosper through this industry over short and long terms. The quantitative analysis includes our authentic findings out of this research study where we provided additional insight into what our readers can do to embrace new opportunities or plan against threats that might hinder the market.

In terms of COVID 19 impact, the Active Pharmaceutical Ingredients Market report also includes the following data points:

  • COVID19 Impact on Active Pharmaceutical Ingredients Market size
  • End-User/Industry/Application Trend, and Preferences
  • Government Policies/Regulatory Framework
  • Key Players Strategy to Tackle Negative Impact/Post-COVID Strategies
  • Opportunity in Active Pharmaceutical Ingredients Market

Buy Latest Copy of Report Now at Higher Discount:

Key Players

Some of the major Active Pharmaceutical Ingredients Market players holding high market share include Sun Pharmaceutical Industries Ltd., Pfizer Inc., Novartis AG and Actavis plc. These players use partnership and collaboration as a key strategy to gain significant market share to compete with market leaders.

The key players profiled in the report are:

  • Reddy’s Laboratories
  • Hospira Inc
  • Teva Pharmaceutical Industries Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Pfizer Inc.
  • Novartis AG
  • Actavis plc
  • Lonza Group AG
  • Mylan N.V.

Segmental Analysis

Market Segment By Type with focus on market share, consumption trend, and growth rate of Active Pharmaceutical Ingredients Market:

  • Innovative Drugs
  • Generic Prescription
  • Over-the-counter (OTC) Drugs

Market Segment By Application with focus on market share, consumption trend, and growth rate of Active Pharmaceutical Ingredients Market:

  • Oncology Drugs
  • Non-steroidal Anti-inflammatory Drugs
  • Cardiovascular Drugs
  • Anti-diabetic Drugs
  • Neurology Drugs
Parameters Details
Market Size (2022) $ 210.5 Billion
CAGR (2023 to 2030) 7.2%
Market Segmentation Type, Application
Country Covered US, Canada, Mexico, UK, Germany, France, Italy, Spain, Nordic Countries, BeNeLux, Rest of Europe, China, India, Japan, South Korea, Indonesia, Malaysia, Australia, Rest of Asia Pacific, Middle East & Africa, and South America

For more information:

Global Active Pharmaceutical Ingredients Market Geographic Coverage:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Indonesia
    • Malaysia
    • Australia
    • Rest of Asia Pacific
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • South Africa
    • Rest of MEA
  • Latin America
    • Mexico
    • Brazil
    • Argentina
    • Rest of Latin America

Reasons to Buy this Report:

  • Detail analysis of the impact of market drivers, restraints, and opportunities
  • Competitive Intelligence providesan understanding of the ecosystem
  • Details analysis of the Total Addressable Market (TAM) of your products
  • Investment Pockets and New Business Opportunities
  • Demand-supply gap analysis
  • Strategy Planning

About EvolveBI
Evolve Business Intelligence is a market research, business intelligence, and advisory firm providing innovative solutions to challenging pain points of a business. Our market research reports include data useful to micro, small, medium, and large-scale enterprises. We provide solutions ranging from mere data collection to business advisory.

Evolve Business Intelligence is built on account of technology advancement providing highly accurate data through our in-house AI-modelled data analysis and forecast tool – EvolveBI. This tool tracks real-time data including, quarter performance, annual performance, and recent developments from fortune’s global 2000 companies.

Evolve Business Intelligence
C-218, 2nd floor, M-Cube
Gujarat 396191





Leave a Reply

Your email address will not be published. Required fields are marked *